Central Banks
Markets
BLS Data
Advanced News
Academy
Economic Calendar
Toggle theme
登录
注册
EL7.AI 上提供的信息仅供教育和参考目的，不构成财务建议。
Aurinia Pharmaceuticals Appoints Kevin Tang as CEO Amid Strong Lupkynis Sales Growth | EL7.AI
累积中
stocks
Aurinia Pharmaceuticals Appoints Kevin Tang as CEO Amid Strong Lupkynis Sales Growth
首次检测到:
Mar 27, 2026, 8:34 PM
最后更新:
about 20 hours ago
4 篇文章
·
4 条报道
受影响的品种
AUPH
时间轴
Scholar Rock De-risks Apitegromab Launch Path Following FDA Resolution
Mar 28, 2026, 2:46 PM
Impact: 6
Bristol-Myers Squibb Reports Positive Phase 4 Data for Schizophrenia Drug Cobenfy
Mar 28, 2026, 2:32 PM
Impact: 6
Aurinia Pharmaceuticals Appoints Kevin Tang as CEO Amid Strong Lupkynis Sales Growth
Mar 27, 2026, 8:34 PM
Impact: 7
